Eosinophil-mast cell pattern of intraepithelial infiltration as a marker of severity in CRSwNP.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
26 07 2023
Historique:
received: 04 05 2023
accepted: 20 07 2023
medline: 28 7 2023
pubmed: 27 7 2023
entrez: 26 7 2023
Statut: epublish

Résumé

Chronic rhinosinusitis with nasal polyps (CRSwNP) is defined as a Type 2 eosinophilic disease, while CRSsNP is considered a Type 1 neutrophilic disease. Since neutrophils are also activated in eosinophilic CRSwNP, the eosinophil-neutrophil dualism has been revaluated. Among the inflammatory cells infiltrating sinus-nasal tissues, the role of mast cells (MCs) is not already recognized, although Clinical-Cytological Grading, which defines the severity of CRSwNP, attributes to mixed eosinophil-MC forms of CRSwNP a greater risk of recurrence. We aimed to examine nasal polyps from both a cytological and histopathological point of view, to evaluate the presence and localization of MCs. Cytological and histological examination of 39 samples of nasal polyps were performed. Immunohistochemistry was used to evaluate the presence of Tryptase + CD117 + MCs, which were counted both in the epithelial layer and in the lamina propria. A statistically significant correlation was found between intraepithelial MCs and CRSwNP severity (p < 0.001) and between the total eosinophil count and the total mast cell count (p < 0.001). Cytological examination and immunohistochemistry were comparable in detecting the presence of intraepithelial MCs (p = 0.002). The histological cut-off of 6 intraepithelial MCs was identified to detect severe CRSwNP (p < 0.001). MCs have been shown to be located in the lamina propria of almost all eosinophilic nasal polyps without significantly affecting their severity. Intraepithelial MCs are associated with greater severity of CRSwNP. Histopathological criteria of the eosinophil-MC form of CRSwNP in addition to the eosinophilic one, should be defined to guarantee patients effective and tailored treatments.

Identifiants

pubmed: 37495667
doi: 10.1038/s41598-023-39149-8
pii: 10.1038/s41598-023-39149-8
pmc: PMC10372103
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

12101

Informations de copyright

© 2023. The Author(s).

Références

J Allergy Clin Immunol. 2020 Jan;145(1):103-104
pubmed: 31738995
J Biol Regul Homeost Agents. 2009 Jul-Sep;23(3):181-8
pubmed: 19828095
J Allergy Clin Immunol. 2020 Jan;145(1):427-430.e4
pubmed: 31493418
Dig Liver Dis. 2011 Mar;43 Suppl 4:S385-95
pubmed: 21459344
Mod Pathol. 2023 Feb;36(2):100005
pubmed: 36853780
J Allergy Clin Immunol. 2010 Nov;126(5):962-8, 968.e1-6
pubmed: 20810157
Ultrastruct Pathol. 2011 Dec;35(6):251-5
pubmed: 21932987
Int Forum Allergy Rhinol. 2022 Nov;12(11):1377-1386
pubmed: 35363947
Am J Otolaryngol. 2022 May-Jun;43(3):103447
pubmed: 35428533
Sci Immunol. 2021 Feb 26;6(56):
pubmed: 33637594
Int Arch Allergy Immunol. 2004 Nov;135(3):196-204
pubmed: 15467372
J Allergy Clin Immunol. 2020 Aug;146(2):337-343.e6
pubmed: 32417132
Rhinology. 2020 Feb 20;58(Suppl S29):1-464
pubmed: 32077450
Clin Exp Allergy. 2014 Feb;44(2):173-83
pubmed: 24330324
Front Immunol. 2020 Sep 24;11:571085
pubmed: 33072112
N Engl J Med. 2016 Jun 23;374(25):2465-76
pubmed: 27332905
Acta Otorhinolaryngol Ital. 2017 Feb;37(1):38-45
pubmed: 28374869
Clin Exp Allergy. 2016 Jun;46(6):785-92
pubmed: 27009397
Acta Otorhinolaryngol Ital. 2022 Feb;42(1):75-81
pubmed: 35292789
Am J Rhinol Allergy. 2021 Sep;35(5):559-567
pubmed: 33302694
Int J Mol Sci. 2021 Feb 28;22(5):
pubmed: 33671092
Front Allergy. 2022 Apr 06;3:768408
pubmed: 35966227
Laryngoscope. 2019 Mar;129(3):E110-E117
pubmed: 30570137
J Allergy Clin Immunol. 2022 Jun;149(6):1919-1925
pubmed: 35427642
Dis Esophagus. 2017 Feb 1;30(3):1-8
pubmed: 26857345
J Allergy Clin Immunol Pract. 2019 Nov - Dec;7(8):2812-2820.e3
pubmed: 31128376
Cell Tissue Res. 2022 Dec;390(3):413-428
pubmed: 36125550
Science. 2019 May 24;364(6442):
pubmed: 31123109
Acta Otorhinolaryngol Ital. 2021 Dec;41(6):576-577
pubmed: 34928269
Allergy. 2006 Nov;61(11):1280-9
pubmed: 17002703
J Allergy Clin Immunol. 2021 Aug;148(2):327-335
pubmed: 33895002
Rhinology. 2022 Jun 1;60(3):162-168
pubmed: 35230355
Am J Rhinol Allergy. 2022 Mar;36(2):229-237
pubmed: 34647485
J Allergy Clin Immunol. 2022 May;149(5):1666-1674
pubmed: 34953792
Int Arch Allergy Immunol. 2022;183(2):153-159
pubmed: 34551414
J Allergy Clin Immunol. 2020 Mar;145(3):740-750
pubmed: 32145873
Rhinology. 2022 Apr 19;:
pubmed: 35438689
Nutrients. 2021 May 15;13(5):
pubmed: 34063411
Semin Diagn Pathol. 2014 Mar;31(2):124-36
pubmed: 24815938
Gastroenterology Res. 2021 Aug;14(4):220-226
pubmed: 34527091
Int J Mol Sci. 2021 Oct 19;22(20):
pubmed: 34681933
Biomedicines. 2022 Jun 09;10(6):
pubmed: 35740385
World Allergy Organ J. 2019 Aug 09;12(8):100050
pubmed: 31452831
Int Arch Allergy Immunol. 2021;182(1):65-75
pubmed: 32927462

Auteurs

Matteo Gelardi (M)

Unit of Otolaryngology, Department of Clinical and Experimental Medicine, University of Foggia, Via Luigi Pinto 1, 71122, Foggia, Italy.

Rossana Giancaspro (R)

Unit of Otolaryngology, Department of Clinical and Experimental Medicine, University of Foggia, Via Luigi Pinto 1, 71122, Foggia, Italy. rogianca@live.it.

Loren Duda (L)

Unit of Pathology, Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.

Vitaliano Nicola Quaranta (VN)

Section of Respiratory Disease, Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari Aldo Moro, Bari, Italy.

Cristina Pizzulli (C)

Unit of Pathology, Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.

Eugenio Maiorano (E)

Section of Pathology, Department of Emergency and Organ Transplantation (DETO), University of Bari "Aldo Moro", 70124, Bari, Italy.

Filomena Milena Di Canio (FM)

Unit of Otolaryngology, Department of Clinical and Experimental Medicine, University of Foggia, Via Luigi Pinto 1, 71122, Foggia, Italy.

Annamaria Ruzza (A)

Unit of Otolaryngology, Department of Clinical and Experimental Medicine, University of Foggia, Via Luigi Pinto 1, 71122, Foggia, Italy.

Lucia Iannuzzi (L)

Otolaryngology Unit, Department of Basic Medical Science, Neuroscience and Sensory Organs, University of Bari Aldo Moro, Bari, Italy.

Nicola Antonio Adolfo Quaranta (NAA)

Otolaryngology Unit, Department of Basic Medical Science, Neuroscience and Sensory Organs, University of Bari Aldo Moro, Bari, Italy.

Francesca Parisi (F)

HNO Klinik, Kantonsspital Aarau, Aarau, Switzerland.

Michele Cassano (M)

Unit of Otolaryngology, Department of Clinical and Experimental Medicine, University of Foggia, Via Luigi Pinto 1, 71122, Foggia, Italy.

Andrea Marzullo (A)

Section of Pathology, Department of Emergency and Organ Transplantation (DETO), University of Bari "Aldo Moro", 70124, Bari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH